- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/647 - One oxygen atom attached in position 2 or 6 and having in the molecule an acyl radical containing a saturated three-membered ring, e.g. chrysanthemumic acid esters
Patent holdings for IPC class C07D 213/647
Total number of patents in this class: 18
10-year publication summary
|
1
|
2
|
2
|
1
|
1
|
3
|
3
|
2
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 2136 |
2 |
| Chengdu Anticancer Bioscience Ltd | 23 |
2 |
| Bayer AG | 3210 |
1 |
| Cisen Pharmaceutical Co., Ltd. | 25 |
1 |
| Nihon Nohyaku Co., Ltd. | 315 |
1 |
| Raqualia Pharma Inc. | 120 |
1 |
| Xuanzhu Pharma Co., Ltd. | 52 |
1 |
| Inflazome Limited | 91 |
1 |
| Padlock Therapeutics, Inc. | 11 |
1 |
| Shanghai Jia Tan PharmaTech Co. Ltd. | 19 |
1 |
| Morphic Therapeutic, Inc. | 41 |
1 |
| Kallyope, Inc. | 52 |
1 |
| XENIOPRO GmbH | 15 |
1 |
| Inipharm, Inc. | 25 |
1 |
| Merck Sharp & Dohme LLC | 3752 |
1 |
| J. Michael Bishop Institute of Cancer Research | 5 |
1 |
| Other owners | 0 |